McDonnell J, Busschbach J J, Kok E, van Exel J, Stolk E, Koopmanschap M, Rutten F F
Institute for Medical Technology Assessment, Erasmus University, PO Box 1738, NL-3000 DR Rotterdam, The Netherlands.
Eur Urol. 2001;39 Suppl 3:37-41. doi: 10.1159/000052566.
Given the ageing of western populations, the cost burden associated with the treatment of LUTS suggestive of BPO will increase substantially over the next few decades. Therefore, from the economic perspective, the primary objective of the Triumph project is the assessment of the cost-effectiveness of treatment options for lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO), formerly referred to as symptomtic benign prostatic hyperplasia (BPH), in medical practice in initially six European countries. All modalities of LUTS treatment used in these countries will be considered. The effectiveness and costs associated with these treatments will be assessed in each country. Data will be gathered from observed medical practice rather than in the setting of a trial. Country-specific aspects will be studied and the outcome of country-specific policies can be predicted. Patient quality of life will also be measured using the I-PSS score as a basis. A number of treatment scenarios will be assessed in terms of both their costs and long-term effects, using a computer simulation. These economic analyses will provide greatly improved insight into the most cost-effective treatments for LUTS suggestive of BPO.
鉴于西方人口老龄化，在未来几十年里，与疑似良性前列腺增生（BPO）的下尿路症状（LUTS）治疗相关的成本负担将大幅增加。因此，从经济角度来看，Triumph项目的主要目标是评估在最初六个欧洲国家的医疗实践中，针对疑似良性前列腺梗阻（BPO），以前称为症状性良性前列腺增生（BPH）的下尿路症状（LUTS）的治疗方案的成本效益。将考虑这些国家使用的所有LUTS治疗方式。将在每个国家评估这些治疗的有效性和成本。数据将从观察到的医疗实践中收集，而不是在试验环境中收集。将研究各国的具体情况，并预测各国特定政策的结果。患者生活质量也将以国际前列腺症状评分（I-PSS）为基础进行测量。将使用计算机模拟，从成本和长期效果两方面评估多种治疗方案。这些经济分析将大大增进对疑似BPO的LUTS最具成本效益治疗方法的了解。
